Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Northstar Global Business Services
HOLBROOK, N.Y., June 18, 2014 /PRNewswire/ -- Northstar Global Business Services, Inc., Symbol (OTCPink:MDIN) today announced that the company's CEO, Justin Sindelman, will be appearing on the popular internet radio show, Pot Stock radio, at http://tinyurl.com/pjcc4aw on Monday, June 23rd at 8pm EST. Also appearing on the show will be Megan Schwarting of Kush Creams, to discuss the recent deal with Northstar and the evolution of both industries that the companies represent. The show's host, Eric Butz, will interview Mr. Sindelman and Ms. Schwarting for approximately one hour. During the interview, both companies intend to share exciting information about their plans moving forward.
Northstar and Kush Creams recently announced a deal, which now looks more like a straight licensing deal than a manufacturing and distribution deal; designed to help insulate Northstar from the unknowns associated with the massive amount of laws and regulations surrounding the medical and recreational marijuana industry. The arrangement has Kush Creams, one of the top legal marijuana producers in the country, producing and distributing Snorenz Medicated, and Snorenz Night Time Medicated, throughout Washington State. The Medicated versions of the popular seller, Snorenz is infused with THC, the active ingredient in Marijuana. Since a non-Washington resident company cannot manufacture or transport THC containing products, Northstar is lending the brand to Kush creams in exchange for a per sale licensing so that the product can hit dispensary shelves in the near future.
"We are ecstatic that Snorenz will be one of the first main stream brands to step over into the medical and recreational marijuana industry, and we believe that although this may seem like a bold move now, in the near future it will be common place. Northstar will be one of the first though, and this is perfectly in line with the tempo we aspire to set. Breaking new ground and pushing forward is one of the traits that will help Northstar to become a household name," commented Mr. Sindelman.
The new Snorenz Medicated will be the first product to hit shelves, and will be available in the coming weeks. The companies have carefully laid plans to rapidly distribute throughout Washington State, mainly thanks to Kush Creams and the elaborate, fast growing distribution network that they already have in place.
Northstar Global Business Services is dedicated to producing the best alternative healthcare products to the world. The company's products include Snorenz®, Good Night's Sleep®, Stem-Intense, and more. Most of the company's products use a unique or patented spray delivery system, and all have received rave consumer reviews all over the world, selling millions of units from 1996 to the present. www.medgeninc.com.
About Kush Creams:
Kush Creams is a nationwide leader and industry pioneer in medical cannabis topical pain relief. Founded in 2010 in Washington state, the company has quickly and successfully grown to serve the thriving medical marijuana marketplace and the newly emerging legal cannabis market. Kush Creams currently manufactures an extensive line of over the counter and prescription strength products and has won over a dozen industry awards. www.kushcreams.com.
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
CONTACT: Investor Relations, firstname.lastname@example.org, 877-571-4387
©2012 PR Newswire. All Rights Reserved.